JPRN-jRCT2080220288未知3 期
MK-0431/ONO-5435 Phase III Clinical Study - Glimepiride add-on Study for Patients with Type 2 Diabetes Mellitus
ONO PHARMACEUTICAL CO.,LTD.0 个研究点开始时间: 2006年8月7日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •The target population is the outpatients >=20 years of age with type 2 diabetes mellitus (male and female) who have inadequate glycemic control on diet/exercise therapy and glimepiride as monotherapy.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT00363519Ono Pharmaceutical Co. Ltd195
未知
3 期
MK-0431/ONO-5435 Phase III Clinical Study - Long-term Treatment Study for Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-jRCT2080220289ONO PHARMACEUTICAL CO.,LTD.
未知
3 期
MK-0431/ONO-5435 Phase III Clinical Study - Metformin add-on Study for Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-jRCT2080220287ONO PHARMACEUTICAL CO.,LTD.
进行中（未招募）
1 期
Clinical study phase III evaluating the efficacy of Diffusil H Forte sprayEUCTR2007-002478-76-CZybar a.s.110
已完成
3 期
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT00363948Ono Pharmaceutical Co. Ltd188